星空游戏网站免费进入|星空彩票电脑版

摘要/Abstract

摘要：帕金森病（Parkinson’s disease, PD）是一种以黑质纹状体中多巴胺能神经元选择性丢失为特征的神经变性疾病，其发病原因至今不详。多年来，遗传因素和环境因素一直是PD发病机制中研究争论的热点，然而，自发性的PD缺乏遗传因素的迹象，这就使环境因素在PD的病因学中占据了优势地位。百草枯（Paraquat, PQ）是一种结构与1-甲基-4-苯基-1，2，3，6-四氢吡啶（1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine, MPTP）的活性代谢物1-甲基-4-苯基-吡啶（1-methyl-4-phenylpyridinium, MPP⁺）相似的化学物质，而MPP+可诱导神经细胞发生毒性改变，促进神经细胞凋亡机制的发生。目前，有大量文献报道，农业中经常使用的除草剂PQ是PD发病的危险因素之一。本文提出以PQ诱导SH-SY5Y细胞为模型，进行PQ导致PD发病的机制研究。以确定PQ是通过类似于MPP⁺诱导细胞凋亡途径导致PD的发病，还是通过引起细胞内氧化应激的发生或者线粒体功能障碍、蛋白酶体异常等途径导致了PD的发病。并且，进一步研究PQ导致PD发生的分子机制，将对PD的预防和治疗有其重要意义。

关键词:帕金森病,百草枯,凋亡

Abstract:Parkinson’s disease (PD) is a neurodegenerative disorder characterized by selective loss of dopaminergic neurons in the substantia nigra (SN); however, the causes of PD remain unknown. Over the years the etiologic involvement of genetic inheritance versus environmental exposures has been under debate. In this sense, a lack of evidence for heritability of the idiopathic PD has pointed to environmental risk factors as potential contributors to the disease etiology. It is reported that, Paraquat (PQ) (1,1-dimethyl-4,4′-bipyridinium dichloride), a widely used herbicide, was suggested as a potential etiologic factor for the development of PD. Paraquat is structurally similar to the neurotoxin MPP+ (1-methyl-4-phenylpyridinium), the latter being an active metabolite derived from MPTP (1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and being capable of inducing the apoptosis of neural cells. In this paper, we used the model of PQ induced toxicity on SH-SY5Y to study the mechanism underlying its effect in causing dopaminergic cells degeneration and necrosis. To this end, we determined whether PQ activated apoptotic pathways leading to the pathogenesis of PD as MPP+ does, or caused intracellular oxidative stress， mitochondrial dysfunction or proteasome abnormality to induce PD. Intensive study of the molecular mechanisms for PQ induction of PD will be of great value for the prevention and treatment of PD.

Key words:Parkinson&,rsquo,s disease,Paraquat,apoptosis

中图分类号:

R742，R964

田小菲，李建锋，庞灏. 百草枯致神经细胞凋亡与帕金森病的相关性[J]. 神经药理学报, 2011, 1(5): 27-33.

TIAN Xiao-fei, LI Jian-feng, PANG Hao. Paraquat-induced Neuronal Apoptosis Associated with Parkinson's Disease[J]. Acta Neuropharmacologica, 2011, 1(5): 27-33.

参考文献

[1] Matthew James Farrer. Genetics of Parkinson disease: paradigm shifts and future prospects [J]. Nat Rev Genet, 2006,7(4):306-318.

[2] Robert E. Burke. Programmed cell death and Parkinson’s disease[J]. Movement Disorders, 1998, 13(Suppl 1):17-23.

[3] James Parkinson. An essay on the shaking palsy[J]. J Neuropsychiatry Clin Neurosci, 2002, 14(2):223-236.

[4] Christine Klein, Michael G Schlossmacher. The genetics of Parkinson disease: Implications for neurological care[J]. Nat Clin Pract Neurol, 2006, 2(3): 136-146.

[5] Caroline M. Tanner, Ruth Ottman, Samuel M. Goldman, et al. Parkinson disease in twins: an etiologic study[J]. JAMA, 1999, 281(4):341-346.

[6] Rosa A González-Polo, Andrea Rodríguez-Martín, Jose M Morán, et al. Paraquat-induced apoptotic cell death in cerebellar granule cells[J]. Brain Res, 2004, 1011(2):170-176.

[7] Rose A González-Polo, Mireia Niso-Santano, Miguel A Ortíz-Ortíz, et al. Inhibition of paraquat-induced autophagy accelerates the apoptotic cell death in neuroblastoma SH-SY5Y cells[J]. Toxicol Sci, 2007, 97(2):448-458.

[8] Jonathan A Javitch, Robert J D'Amato, Stephen M Strittmatter, et al. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity[J]. Proc Natl Acad Sci USA, 1985, 82(7):2173-2177.

[9] Sai Takafumi, Uchida Kazuyuki, Nakayama Hiroyuki. Acute toxicity of MPTP and MPP(+) in the brain of embryo and newborn mice[J]. Exp Toxicol Pathol, 2011, 65(1-2):113-119.

[10] Chade A R, Kasten M, Tanner C M. Nongenetic causes of Parkinson’s disease[J]. J Neural Transm Suppl, 2006, (70):147-151.

[11] James S Bus, James E Gibson. Paraquat: model for oxidant-initiated toxicity[J]. Environ Health Perspect, 1984, 55:37-46.

[12] Shimizu K, Matsubara K, Ohtaki K, et al. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats[J]. Brain Res, 2003, 976 (2):243–252.

[13] Xie Hong-rong, Hu Lin-sen, Li Guo-yi. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease[J]. Chin Med J (Engl), 2010, 123(8):1086-1092.

[14] James S Bus, James E Gibson. Paraquat: model for oxidant-initiated toxicity[J]. Environ Health Perspect, 1984 ,55:37-46.

[15] Zacharias E Suntres. Role of antioxidants in paraquat toxicity[J]. Toxicology, 2002, 180(1):65-77.

[16] Dodge AD. The mode of action of the bipyridylium herbicides, paraquat and diquat[J]. Endeavour, 1971, 30(111):130-135.

[17] Cappelletti G, Maggioni MG, Maci R. Apoptosis in human lung epithelial cells: triggering by paraquat and modulation by antioxidants[J]. Cell Biol Int, 1998, 22(9-10):671-678.

[18] Li X, Sun AY. Paraquat induced activation of transcription factor AP-1 and apoptosis in PC12 cells[J]. J Neural Transm, 1999, 106(1):1-21.

[19] Vincenzo Mollace, Michelangelo Iannone, Carolina Muscoli, et al. The role of oxidative stress in paraquat-induced neurotoxicity in rats: protection by non peptidyl superoxide dismutase mimetic[J]. Neurosci Lett, 2003, 335(3):163-166.

[20] Pol Gime′ nez-Xavier Pol, Roser Francisco, Antonio F Santidria′n, et al. Effects of dopamine on LC3-II activation as a marker of autophagy in a neuroblastoma cell model[J]. Neurotoxicology, 2009, 30(4):658-665.

[21] Shawna Tazik, Shakevia Johnson, Deyin Lu, et al. Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis[J]. Neurotox Res, 2009, 15(3):284-290.

[22] Danuta Jantas , Wladyslaw Lason . Different mechanisms of NMDA-mediated protection against neuronal apoptosis: a stimuli-dependent effect[J]. Neurochem Res, 2009, 34(11):2040-2054.

[23] 金恵铭,王建枝.病理生理学[M].第六版. 北京: 人民卫生出版社, 2004: 130-134.

[24] James R. Roede , Jason M. Hansen , Young-Mi Go , et al. Maneb and paraquat-mediated neurotoxicity: involvement of peroxiredoxin/thioredoxin system[J]. Toxicol Sci, 2011, 121(2):368-375.

[25] Sanchez-Ramos JR, Hefti F, Weiner WJ. Paraquat and Parkinson's disease[J]. Neurology, 1987, 37(4):728.

[26] Naveen Kumar Singhal , Garima Srivastava , Devendra Kumar Patel ,et al. Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse[J]. J Pineal Res, 2011, 50(2):97-109.

[27] Sadie Costello, Myles Cockburn, Jeff Bronstein, et al. Parkinson’s Disease and Residential Exposure to Maneb and Paraquat From Agricultural Applications in the Central Valley of California[J]. J American Epidemiol, 2009, 169(9):919-926.

[28] Katarzyna Kuter, Maria ?mia?owska, Joanna Wierońska, et al. Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats[J]. Brain Res, 2007, 1155:196–207.

[29] Horng-huei Liou , Rong-chi Chen , Yuan-feen Tsai , et al. Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies[J]. Toxicol Appl Pharmacol, 1996, 137(1):34-41.

[30] Min Jeong Kang , Suk Ju Gil , Hyun Chul Koh . Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice[J]. Toxicol Lett, 2009, 188(2):148-152.

[31] Alison L. McCormack , Jennifer G. Atienza , Louisa C. Johnston , et al. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration[J]. J Neurochem, 2005, 93(4):1030-1037.

[32] A.I Brooks , C.A Chadwick , H.A Gelbard , et al. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss[J]. Brain Res, 1999, 823(1-2):1-10.

[33] Wonsuk Yang , Linan Chen , Yunmin Ding , et al. Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice[J]. Hum Mol Genet, 2007, 16(23):2900-2910.

[34] Pablo R Castello , Derek A Drechsel , Manisha Patel . Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain[J]. J Biol Chem, 2007, 282(19):14186-14193.

[35] R.J Dinis-Oliveira , F. Remião , H. Carmo , et al. Paraquat exposure as an etiological factor of Parkinson's disease[J]. Neurotoxicology, 2006, 27(6):1110-1122.

[36] Masato Enari , Hideki Sakahira , Hideki Yokoyama , et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD [J]. Nature, 1998, 391(6662):43-50.

[37] Aimee L Edinger , Craig B Thompson . Death by design: apoptosis, necrosis and autophagy[J]. Curr Opin Cell Biol, 2004, 16(6):663-669.

[38] 胡野, 凌志强, 单小云, 等. 细胞凋亡的分子生物学[M]. 第一版. 北京: 军事医学科学出版社, 2002:511-515.

[39] Senthil Selvaraj , John A. Watt , Brji B Singh . TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+)[J]. Cell Calcium, 2009,46(3):209-218.

[40] Green Douglas R, Kroemer Guido. The pathophysiology of mitochondrial cell death[J]. Science, 2004, 305(5684):626-629.

[41] Gary Fiskum , Anatoly Starkov , Brain M. Polster , et al. Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease[J]. Ann N Y Acad Sci, 2003, 991:111-119.

[42] Fei Qingyan, Alison L. McCormack, Donato A. Di Monte, et al. Paraquat neurotoxicity is mediated by a Bak-dependent mechanism[J]. J Biol Chem, 2008, 283(6):3357-3364.

[43] Miquel Vila , David Ramonet , Celine Perier . Mitochondrial alterations in Parkinson’s disease: new clues[J]. J Neurochem, 2008, 107(2):317-328.

[44] Oren A Levy , Cristina Malagelada , LloydA Greene .Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps[J]. Apoptosis, 2009, 14(4):478-500.

[45] Mireia Niso-Santano , Jose M. Morán , Lourdes García-Rubio , et al. Low concentrations of paraquat induces early activation of extracellular signal-regulated kinase 1/2, protein kinase B, and c-Jun N-terminal kinase 1/2 pathways: role of c-Jun N-terminal kinase in paraquat-induced cell death[J]. Toxicol Sci, 2006, 92(2):507-515.

[46] Sarah J Harper , Philip LoGrasso . Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38[J]. Cell Signal, 2001, 13(5):299-310.

[47] Cha Guang-Ho, Kim Sunhong, Park Jeehye, et al. Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila[J]. Proc Natl Acad Sci USA, 2005, 102(29):10345-10350.

[48] Anna C. Maroney , James P. Finn , Thomas J. Connors , et al. Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family[J]. J Biol Chem, 2001, 276(27):25302-25308.

[49] Michael S. Saporito, Ellen M Brown, Matthew S. Miller, et al. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4- phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo[J]. J Pharmacol Exp Ther, 1999, 288(2):421–427.

[50] Xia Xu-Gang, Harding Thomas, Weller Michael, et al. Gene transfer of the JNK interacting protein- 1 protects dopaminergic neurons in the MPTP model of Parkinson’s disease[J]. Proc Natl Acad Sci USA, 2001, 98(18): 10433–10438.

[51] González-Polo Rosa A, Soler German, Alvarez Alberto, et al. Vitamin E blocks early events induced by 1-methyl-4-phenylpyridinium (MPP+) in cerebellar granule cells[J]. J Neurochem, 2003, 84(2):305-315.

[52] Jose M Moran , Rosa A. Gonzalez-Polo , Miguel A. Ortiz-Ortiz , et al. Identification of genes associated with paraquat-induced toxicity in SH-SY5Y cells by PCR array focused on apoptotic pathways[J]. J Toxicol Environ Health A, 2008, 71(22):1457-1467.

[53] Hirsch EC, Hunot S. Neuroinflammation in Parkinson’s disease: a target for neuroprotection? [J]. Lancet Neurol, 2009, 8(4): 382–397.

[54] Miquel Vila , Vernice Jackson-Lewis , Slobodanka Vukosavic , et al. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease[J]. Proc Natl Acad Sci U S A, 2001, 98(5):2837-2842.

[55] Javier Simón-Sánchez , Claudia Schulte , Jose M. Bras , et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease[J]. Nat Genet, 2009, 41(12):1308-1312.

[56] 鞠躬, 吕国蔚, 王百忍, 等. 神经生物学[M]. 第一版. 北京: 人民卫生出版社, 2004:654-659.

[57] Simunovic Filip, Yi Ming, Wang Yulei, et al. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology[J]. Brain, 2009, 132(Pt 7):1795-1809.

[58] Gollamudi Seema, Johri Ashu, Calingasan Noel Y, et al. Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease[J]. PLoS One, 2012,7(5):e36191.

百草枯致神经细胞凋亡与帕金森病的相关性

Paraquat-induced Neuronal Apoptosis Associated with Parkinson's Disease

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

[1]	朱静怡, 樊建春, 禹爱梅.普罗布考在保护神经系统中的研究现状[J]. 神经药理学报, 2023, 13(6): 50-.
[2]	李双燕, 张兴池, 赵巧妙, 侯奕冰, 冉子恒, 田莹, 薛占霞.CTLA4-Ig 改善EAMG 大鼠脑功能障碍的分子机制研究[J]. 神经药理学报, 2022, 12(4): 1-9.
[3]	蔡雨珊, 赵帅.PPARβ/δ在神经退行性疾病中的研究进展[J]. 神经药理学报, 2022, 12(4): 41-48.
[4]	李晨阳, 赵姣娇, 张炜.柴胡- 黄芩调控中枢神经系统功能研究进展[J]. 神经药理学报, 2022, 12(4): 49-57.
[5]	崔佩, 孙玉姣, 陈晶晶, 张馨予, 董艳红.加速重复经颅磁刺激应用的研究进展[J]. 神经药理学报, 2022, 12(3): 23-.
[6]	孙丽, 张晓莹, 高广生.S14G-humanin 对氧糖剥夺/ 复氧神经细胞损伤的保护作用[J]. 神经药理学报, 2022, 12(2): 1-.
[7]	董露露, 王璐璐, 陈景红, 等.帕金森病异动症的影响因素及其相关机制的研究[J]. 神经药理学报, 2022, 12(2): 53-.
[8]	郝艳娇, 李志宇, 常明智, 等.PI3K-AKT 信号通路在胃癌中的作用机制及研究进展[J]. 神经药理学报, 2021, 11(6): 53-.
[9]	潘妍婷, 张晓杰, 范磊, 刘星亮, 岳秉宏. 帕金森病合并糖尿病患者的情绪与认知及肢体感觉异常的研究[J]. 神经药理学报, 2021, 11(4): 1-.
[10]	沈原, 黄树其, 张凯. α-突触核蛋白对内质网应激及细胞凋亡影响[J]. 神经药理学报, 2021, 11(2): 1-4.
[11]	叶三川. 黄芪颗粒对老年痴呆性大鼠海马组织细胞凋亡的影响[J]. 神经药理学报, 2021, 11(2): 11-14.
[12]	钱麒炳, 王金瑛, 赵晨宇, 等. 大鼠脊髓损伤模型的制备与评估[J]. 神经药理学报, 2021, 11(2): 21-25.
[13]	翁英华.阿托伐他汀钙对非心源性缺血性脑卒中大鼠神经功能的影响[J]. 神经药理学报, 2020, 10(6): 13-17.
[14]	吴健, 黄玉梅, 张玲玲, 吕秀华.阿司匹林对缺血性脑梗死神经元细胞凋亡的影响及机制[J]. 神经药理学报, 2020, 10(6): 18-22.
[15]	李兆珍, 张丹参.脑缺血再灌注损伤相关机制的研究进展[J]. 神经药理学报, 2020, 10(6): 60-63.